{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,3]],"date-time":"2026-09-03T17:14:12Z","timestamp":1788455652297,"version":"build-2803163510"},"reference-count":80,"publisher":"Springer Science and Business Media LLC","license":[{"start":{"date-parts":[[2026,9,3]],"date-time":"2026-09-03T00:00:00Z","timestamp":1788393600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,9,3]],"date-time":"2026-09-03T00:00:00Z","timestamp":1788393600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"DOI":"10.13039\/100006492","name":"Division of Intramural Research, National Institute of Allergy and Infectious Diseases","doi-asserted-by":"publisher","award":["R01AI150358"],"award-info":[{"award-number":["R01AI150358"]}],"id":[{"id":"10.13039\/100006492","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100006492","name":"Division of Intramural Research, National Institute of Allergy and Infectious Diseases","doi-asserted-by":"publisher","award":["P30AI50410"],"award-info":[{"award-number":["P30AI50410"]}],"id":[{"id":"10.13039\/100006492","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["AIDS Behav"],"DOI":"10.1007\/s10461-026-05198-z","type":"journal-article","created":{"date-parts":[[2026,9,3]],"date-time":"2026-09-03T04:23:57Z","timestamp":1788409437000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Women\u2019s Perceptions of Novel 3-D Printed Vaginal Rings for Multipurpose Prevention"],"prefix":"10.1007","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-5546-3163","authenticated-orcid":false,"given":"Carol","family":"Golin","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ella","family":"Ferguson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elizabeth","family":"Millar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jaya","family":"Mishra","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christina","family":"Perez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eliza","family":"Schenck","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lauren","family":"Richey","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sarah","family":"Ball","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rima","family":"Janusziewicz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S. Rahima","family":"Benhabbour","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kate M.","family":"Guthrie","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,9,3]]},"reference":[{"key":"5198_CR1","doi-asserted-by":"publisher","first-page":"e1152","DOI":"10.1016\/S2214-109X(20)30315-6","volume":"8","author":"J Bearak","year":"2020","unstructured":"Bearak J, Popinchalk A, Ganatra B, Moller A-B, Tun\u00e7alp \u00d6, Beavin C, et al. Unintended pregnancy and abortion by income, region, and the legal status of abortion: estimates from a comprehensive model for 1990\u20132019. Lancet Glob Health. 2020;8:e1152\u201361. https:\/\/doi.org\/10.1016\/S2214-109X(20)30315-6.","journal-title":"Lancet Glob Health"},{"key":"5198_CR2","unstructured":"Global AIDS report \u2014 The urgency of now. AIDS at a Crossroads | UNAIDS. (2024) https:\/\/www.unaids.org\/en\/resources\/documents\/2024\/global-aids-update-2024. Accessed 18 June 2025."},{"key":"5198_CR3","doi-asserted-by":"publisher","first-page":"210","DOI":"10.1136\/bmjsrh-2021-201356","volume":"49","author":"CI Gotsche","year":"2023","unstructured":"Gotsche CI, Steyn PS, Narasimhan M, Rodolph M, Baggaley R, Kiarie JN. Integrating pre-exposure prophylaxis of HIV infection into family planning services: a scoping review. BMJ Sex Reprod Health. 2023;49:210\u20138. https:\/\/doi.org\/10.1136\/bmjsrh-2021-201356.","journal-title":"BMJ Sex Reprod Health"},{"key":"5198_CR4","doi-asserted-by":"publisher","first-page":"1008788","DOI":"10.3389\/frph.2022.1008788","volume":"4","author":"KA Johnson","year":"2022","unstructured":"Johnson KA, Binion S, Waller B, Sutton A, Wilkes S, Payne-Foster P, et al. Left behind in the U.S.\u2019 Deep South: Addressing critical gaps in HIV and intimate partner violence prevention efforts targeting Black women. Front Reprod Health. 2022;4:1008788. https:\/\/doi.org\/10.3389\/frph.2022.1008788.","journal-title":"Front Reprod Health"},{"key":"5198_CR5","unstructured":"Diagnoses CDCHIV. Deaths, and prevalence. HIV Data. (2025).\u00a0https:\/\/www.cdc.gov\/hiv-data\/nhss\/hiv-diagnoses-deaths-prevalence.html. Accessed 28 Jan 2026."},{"key":"5198_CR6","doi-asserted-by":"publisher","first-page":"10","DOI":"10.2174\/1874613602115010010","volume":"15","author":"N Nwangwu-Ike","year":"2017","unstructured":"Nwangwu-Ike N, Jin C, Gant Z, Johnson S, Balaji AB. An Examination of Geographic Differences in Social Determinants of Health Among Women with Diagnosed HIV in the United States and Puerto Rico, 2017. Open AIDS J. 2017;15:10\u201320. https:\/\/doi.org\/10.2174\/1874613602115010010.","journal-title":"Open AIDS J"},{"key":"5198_CR7","doi-asserted-by":"publisher","first-page":"e0172367","DOI":"10.1371\/journal.pone.0172367","volume":"12","author":"A Breskin","year":"2017","unstructured":"Breskin A, Adimora AA, Westreich D. Women and HIV in the United States. PLoS One. 2017;12:e0172367. https:\/\/doi.org\/10.1371\/journal.pone.0172367.","journal-title":"PLoS One"},{"key":"5198_CR8","doi-asserted-by":"publisher","first-page":"701","DOI":"10.1016\/j.socscimed.2004.06.021","volume":"60","author":"B Lichtenstein","year":"2005","unstructured":"Lichtenstein B. Domestic violence, sexual ownership, and HIV risk in women in the American deep south. Soc Sci Med. 2005;60:701\u201314. https:\/\/doi.org\/10.1016\/j.socscimed.2004.06.021.","journal-title":"Soc Sci Med"},{"key":"5198_CR9","doi-asserted-by":"publisher","first-page":"865","DOI":"10.1007\/s10461-011-9998-7","volume":"17","author":"RA Crosby","year":"2013","unstructured":"Crosby RA, DiClemente RJ, Salazar LF, Wingood GM, McDermott-Sales J, Young AM, et al. Predictors of Consistent Condom Use Among Young African American Women. AIDS Behav. 2013;17:865\u201371. https:\/\/doi.org\/10.1007\/s10461-011-9998-7.","journal-title":"AIDS Behav"},{"key":"5198_CR10","doi-asserted-by":"publisher","first-page":"844","DOI":"10.1007\/s10900-017-0325-8","volume":"42","author":"S Reif","year":"2017","unstructured":"Reif S, Safley D, McAllaster C, Wilson E, Whetten K. State of HIV in the US Deep South. J Community Health. 2017;42:844\u201353.","journal-title":"J Community Health"},{"key":"5198_CR11","doi-asserted-by":"publisher","first-page":"606","DOI":"10.1016\/j.jconrel.2023.10.006","volume":"363","author":"IC Young","year":"2023","unstructured":"Young IC, Pallerla A, Cottrell ML, Maturavongsadit P, Prasher A, Shrivastava R, et al. Long-acting injectable multipurpose prevention technology for prevention of HIV and unplanned pregnancy. J Control Release. 2023;363:606\u201320. https:\/\/doi.org\/10.1016\/j.jconrel.2023.10.006.","journal-title":"J Control Release"},{"key":"5198_CR12","doi-asserted-by":"publisher","first-page":"e0185946","DOI":"10.1371\/journal.pone.0185946","volume":"12","author":"JM Smith","year":"2017","unstructured":"Smith JM, Moss JA, Srinivasan P, Butkyavichene I, Gunawardana M, Fanter R, et al. Novel multipurpose pod-intravaginal ring for the prevention of HIV, HSV, and unintended pregnancy: Pharmacokinetic evaluation in a macaque model. PLOS ONE Public Libr Sci. 2017;12:e0185946. https:\/\/doi.org\/10.1371\/journal.pone.0185946.","journal-title":"PLOS ONE Public Libr Sci"},{"key":"5198_CR13","doi-asserted-by":"publisher","first-page":"1147628","DOI":"10.3389\/frph.2023.1147628","volume":"5","author":"MK Shapley-Quinn","year":"2023","unstructured":"Shapley-Quinn MK, Song M, Chen BA, Devlin B, Luecke E, Brown J, et al. Participant experiences with a multipurpose vaginal ring for HIV and pregnancy prevention during a phase 1 clinical trial: learning from users to improve acceptability. Front Reprod Health. 2023;5:1147628. https:\/\/doi.org\/10.3389\/frph.2023.1147628.","journal-title":"Front Reprod Health"},{"key":"5198_CR14","doi-asserted-by":"publisher","first-page":"e0263664","DOI":"10.1371\/journal.pone.0263664","volume":"17","author":"MCD Stoner","year":"2022","unstructured":"Stoner MCD, Browne EN, Gundacker HM, Hawley I, Chen BA, Hoesley C, et al. Acceptability of an extended duration vaginal ring for HIV prevention and interest in a multi-purpose ring. PLoS ONE. 2022;17:e0263664. https:\/\/doi.org\/10.1371\/journal.pone.0263664.","journal-title":"PLoS ONE"},{"key":"5198_CR15","doi-asserted-by":"publisher","first-page":"532","DOI":"10.1071\/SH15045","volume":"12","author":"U Das","year":"2015","unstructured":"Das U, Sharma M, Kilbourne-Brook M, Coffey PS. Exploring vaginal ring acceptability for contraception and sexually transmissible infection protection in India: a qualitative research study. Sex Health. 2015;12:532\u201340. https:\/\/doi.org\/10.1071\/SH15045.","journal-title":"Sex Health"},{"key":"5198_CR16","doi-asserted-by":"publisher","DOI":"10.1016\/j.biomaterials.2023.122260","author":"IC Young","year":"2023","unstructured":"Young IC, Srinivasan P, Shrivastava R, Janusziewicz R, Thorson A, Cottrell ML, et al. Next generation 3D-printed intravaginal ring for prevention of HIV and unintended pregnancy. Biomaterials [Internet]. 2023. https:\/\/doi.org\/10.1016\/j.biomaterials.2023.122260. [cited 2025 June 18];301.","journal-title":"Biomaterials [Internet]"},{"key":"5198_CR17","doi-asserted-by":"publisher","first-page":"e0199778","DOI":"10.1371\/journal.pone.0199778","volume":"13","author":"AR Thurman","year":"2018","unstructured":"Thurman AR, Schwartz JL, Brache V, Clark MR, McCormick T, Chandra N, et al. Randomized, placebo controlled phase I trial of safety, pharmacokinetics, pharmacodynamics and acceptability of tenofovir and tenofovir plus levonorgestrel vaginal rings in women. PLoS ONE. 2018;13:e0199778. https:\/\/doi.org\/10.1371\/journal.pone.0199778.","journal-title":"PLoS ONE"},{"key":"5198_CR18","doi-asserted-by":"publisher","first-page":"e0275794","DOI":"10.1371\/journal.pone.0275794","volume":"17","author":"AR Thurman","year":"2022","unstructured":"Thurman AR, Brache V, Cochon L, Ouattara LA, Chandra N, Jacot T, et al. Randomized, placebo controlled phase I trial of the safety, pharmacokinetics, pharmacodynamics and acceptability of a 90\u00a0day tenofovir plus levonorgestrel vaginal ring used continuously or cyclically in women: The CONRAD 138 study. PLoS ONE. 2022;17:e0275794. https:\/\/doi.org\/10.1371\/journal.pone.0275794.","journal-title":"PLoS ONE"},{"key":"5198_CR19","doi-asserted-by":"publisher","first-page":"2833","DOI":"10.1002\/jps.23208","volume":"101","author":"MM Baum","year":"2012","unstructured":"Baum MM, Butkyavichene I, Gilman J, Kennedy S, Kopin E, Malone AM, et al. An intravaginal ring for the simultaneous delivery of multiple drugs. J Pharm Sci. 2012;101:2833\u201343. https:\/\/doi.org\/10.1002\/jps.23208.","journal-title":"J Pharm Sci"},{"key":"5198_CR20","doi-asserted-by":"publisher","first-page":"203","DOI":"10.1016\/j.ejps.2009.11.007","volume":"39","author":"TJ Johnson","year":"2010","unstructured":"Johnson TJ, Gupta KM, Fabian J, Albright TH, Kiser PF. Segmented polyurethane intravaginal rings for the sustained combined delivery of antiretroviral agents dapivirine and tenofovir. Eur J Pharm Sci Off J Eur Fed Pharm Sci. 2010;39:203\u201312. https:\/\/doi.org\/10.1016\/j.ejps.2009.11.007.","journal-title":"Eur J Pharm Sci Off J Eur Fed Pharm Sci"},{"key":"5198_CR21","doi-asserted-by":"publisher","first-page":"789","DOI":"10.1055\/a-1369-9395","volume":"81","author":"F Rafiei","year":"2021","unstructured":"Rafiei F, Tabesh H, Farzad S, Farzaneh F, Rezaei M, Hosseinzade F, et al. Development of Hormonal Intravaginal Rings: Technology and Challenges. Geburtshilfe Frauenheilkd. 2021;81:789\u2013806. https:\/\/doi.org\/10.1055\/a-1369-9395.","journal-title":"Geburtshilfe Frauenheilkd"},{"key":"5198_CR22","doi-asserted-by":"publisher","first-page":"300","DOI":"10.1016\/j.ijpharm.2018.08.051","volume":"550","author":"DJ Murphy","year":"2018","unstructured":"Murphy DJ, Desjardins D, Boyd P, Dereuddre-Bosquet N, Stimmer L, Caldwell A, et al. Impact of ring size and drug loading on the pharmacokinetics of a combination dapivirine-darunavir vaginal ring in cynomolgus macaques. Int J Pharm. 2018;550:300\u20138. https:\/\/doi.org\/10.1016\/j.ijpharm.2018.08.051.","journal-title":"Int J Pharm"},{"key":"5198_CR23","doi-asserted-by":"publisher","first-page":"2262","DOI":"10.1128\/AAC.02542-13","volume":"58","author":"M Gunawardana","year":"2014","unstructured":"Gunawardana M, Mullen M, Yoo J, Webster P, Moss JA, Baum MM. Sustained Delivery of Commensal Bacteria from Pod-Intravaginal Rings. Antimicrob Agents Chemother. 2014;58:2262\u20137. https:\/\/doi.org\/10.1128\/AAC.02542-13.","journal-title":"Antimicrob Agents Chemother"},{"key":"5198_CR24","doi-asserted-by":"publisher","unstructured":"Tumbleston JR, Shirvanyants D, Ermoshkin N, Janusziewicz R, Johnson AR, Kelly D, et al. Continuous liquid interface production of 3D objects. Science. 2015;347:1349\u201352. https:\/\/doi.org\/10.1126\/science.aaa2397.","DOI":"10.1126\/science.aaa2397"},{"key":"5198_CR25","doi-asserted-by":"publisher","first-page":"11703","DOI":"10.1073\/pnas.1605271113","volume":"113","author":"R Janusziewicz","year":"2016","unstructured":"Janusziewicz R, Tumbleston JR, Quintanilla AL, Mecham SJ, DeSimone JM. Layerless fabrication with continuous liquid interface production. Proc Natl Acad Sci U S A. 2016;113:11703\u20138. https:\/\/doi.org\/10.1073\/pnas.1605271113.","journal-title":"Proc Natl Acad Sci U S A"},{"key":"5198_CR26","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0162518","volume":"11","author":"AR Johnson","year":"2016","unstructured":"Johnson AR, Caudill CL, Tumbleston JR, Bloomquist CJ, Moga KA, Ermoshkin A, et al. Single-step fabrication of computationally designed microneedles by continuous liquid interface production. PloS One. 2016;11:e0162518. https:\/\/doi.org\/10.1371\/journal.pone.0162518.","journal-title":"PloS One"},{"key":"5198_CR27","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1016\/j.jconrel.2018.03.026","volume":"278","author":"CJ Bloomquist","year":"2018","unstructured":"Bloomquist CJ, Mecham MB, Paradzinsky MD, Janusziewicz R, Warner SB, Luft JC, et al. Controlling release from 3D printed medical devices using CLIP and drug-loaded liquid resins. Journal of Controlled Release. 2018;278:9\u201323. https:\/\/doi.org\/10.1016\/j.jconrel.2018.03.026.","journal-title":"Journal of Controlled Release"},{"key":"5198_CR28","doi-asserted-by":"publisher","first-page":"100978","DOI":"10.1016\/j.mtchem.2022.100978","volume":"24","author":"R Janusziewicz","year":"2022","unstructured":"Janusziewicz R, Shrivastava R, Dahl DK, Young IC, Bis M, Whitesell AN, et al. Fundamental investigation of sustained and controlled therapeutics release from 3D printed medical devices. Materials Today Chemistry. 2022;24:100978. https:\/\/doi.org\/10.1016\/j.mtchem.2022.100978.","journal-title":"Materials Today Chemistry"},{"issue":"8","key":"5198_CR29","doi-asserted-by":"publisher","first-page":"2000261","DOI":"10.1002\/admt.202000261","volume":"5","author":"R Janusziewicz","year":"2020","unstructured":"Janusziewicz R, Mecham SJ, Olson KR, Benhabbour SR. Design and characterization of a novel series of geometrically complex intravaginal rings with digital light synthesis. Adv Mater Technol. 2020;5:2000261. https:\/\/doi.org\/10.1002\/admt.202000261.","journal-title":"Adv Mater Technol"},{"issue":"8","key":"5198_CR30","doi-asserted-by":"publisher","first-page":"1030","DOI":"10.3390\/pharmaceutics16081030","volume":"16","author":"IC Young","year":"2024","unstructured":"Young IC, Thorson AL, Cottrell ML, Sykes C, Schauer AP, Sellers RS, et al. Next-generation contraceptive intravaginal ring: comparison of etonogestrel and ethinyl estradiol in vitro and in vivo release from 3D-printed intravaginal ring and NuvaRing. Pharmaceutics. 2024;16:1030. https:\/\/doi.org\/10.3390\/pharmaceutics16081030.","journal-title":"Pharmaceutics"},{"key":"5198_CR31","doi-asserted-by":"publisher","first-page":"2185","DOI":"10.1007\/s11095-025-03969-2","volume":"42","author":"DK Dahl","year":"2025","unstructured":"Dahl DK, Janusziewicz R, Shrivastava R, Maturavongsadit P, Chan E, Montgomery SA, et al. Next generation 3D printed multipurpose intravaginal ring for sustained co-delivery of antiretroviral drugs and a contraceptive hormone. Pharm Res. 2025;42:2185\u2013203. https:\/\/doi.org\/10.1007\/s11095-025-03969-2.","journal-title":"Pharm Res"},{"key":"5198_CR32","doi-asserted-by":"publisher","DOI":"10.1007\/s13346-025-02038-w","author":"SA Howard","year":"2026","unstructured":"Howard SA, Bhutta MS, Janusziewicz R, Trujillo AP, Cohen AL, Doncel GF, et al. First-in-line 3D-printed intravaginal ring for nonhormonal contraception. Drug Deliv Transl Res. 2026. https:\/\/doi.org\/10.1007\/s13346-025-02038-w.","journal-title":"Drug Deliv Transl Res"},{"key":"5198_CR33","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0088509","volume":"9","author":"JT Clark","year":"2014","unstructured":"Clark JT, Clark MR, Shelke NB, Johnson TJ, Smith EM, Andreasen AK, et al. Engineering a Segmented Dual-Reservoir Polyurethane Intravaginal Ring for Simultaneous Prevention of HIV Transmission and Unwanted Pregnancy. PLoS One. 2014;9:e88509. https:\/\/doi.org\/10.1371\/journal.pone.0088509.","journal-title":"PLoS One"},{"key":"5198_CR34","doi-asserted-by":"publisher","first-page":"93","DOI":"10.1097\/QAI.0b013e3180415ded","volume":"45","author":"KM Morrow","year":"1999","unstructured":"Morrow KM, Fava JL, Rosen RK, Vargas S, Barroso C, Christensen AL, et al. Willingness to Use Microbicides Is Affected by the Importance of Product Characteristics, Use Parameters, and Protective Properties. JAIDS J Acquir Immune Defic Syndr. 1999;45:93\u2013101. https:\/\/doi.org\/10.1097\/QAI.0b013e3180415ded.","journal-title":"JAIDS J Acquir Immune Defic Syndr"},{"key":"5198_CR35","doi-asserted-by":"publisher","first-page":"383","DOI":"10.1089\/jwh.2006.0325","volume":"17","author":"RK Rosen","year":"2002","unstructured":"Rosen RK, Morrow KM, Carballo-Di\u00e9guez A, Mantell JE, Hoffman S, Gai F, et al. Acceptability of tenofovir gel as a vaginal microbicide among women in a phase I trial: a mixed-methods study. J Womens Health (Larchmt). 2002;17:383\u201392. https:\/\/doi.org\/10.1089\/jwh.2006.0325.","journal-title":"J Womens Health (Larchmt)"},{"key":"5198_CR36","doi-asserted-by":"publisher","first-page":"1022","DOI":"10.1089\/aid.2015.0275","volume":"32","author":"KM Guthrie","year":"2016","unstructured":"Guthrie KM, Dunsiger S, Vargas SE, Fava JL, Shaw JG, Rosen RK, et al. Perceptibility and the \u201cChoice Experience\u201d: User Sensory Perceptions and Experiences Inform Vaginal Prevention Product Design. AIDS Res Hum Retroviruses. 2016;32:1022\u201330. https:\/\/doi.org\/10.1089\/aid.2015.0275.","journal-title":"AIDS Res Hum Retroviruses"},{"key":"5198_CR37","doi-asserted-by":"publisher","first-page":"1343","DOI":"10.1089\/jwh.2021.0394","volume":"31","author":"EE Tolley","year":"2022","unstructured":"Tolley EE, Zissette S, Taylor J, Hanif H, Ju S, Schwarz J, et al. Acceptability of a long-acting, multipurpose vaginal ring: findings from a phase I trial in the U.S. and dominican republic. J Womens Health. 2022;31:1343\u201352. https:\/\/doi.org\/10.1089\/jwh.2021.0394.","journal-title":"J Womens Health"},{"key":"5198_CR38","doi-asserted-by":"publisher","first-page":"3615","DOI":"10.1007\/s10461-024-04421-z","volume":"28","author":"AM Young","year":"2024","unstructured":"Young AM, Stoner MCD, Mathebula F, Mohuba R, Baez A, Seyama L, et al. Acceptability of the Dapivirine Vaginal Ring and Daily Oral Pre-exposure Prophylaxis (PrEP) during Pregnancy in Malawi, South Africa, Uganda, and Zimbabwe. AIDS Behav. 2024;28:3615\u201328. https:\/\/doi.org\/10.1007\/s10461-024-04421-z.","journal-title":"AIDS Behav"},{"key":"5198_CR39","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pgph.0004081","volume":"5","author":"N Taruberekera","year":"2025","unstructured":"Taruberekera N, Munjoma M, Mugurungi O, Ncube G, Mutseta M, Dhodho M, et al. A mixed-method study of feasibility and acceptability of the Dapivirine vaginal ring among adolescent girls and young women (AGYW) in selected Zimbabwean districts. PLoS Glob Public Health. 2025;5:e0004081. https:\/\/doi.org\/10.1371\/journal.pgph.0004081.","journal-title":"PLoS Glob Public Health"},{"key":"5198_CR40","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0145642","volume":"10","author":"K Morrow Guthrie","year":"2015","unstructured":"Morrow Guthrie K, Vargas S, Shaw JG, Rosen RK, van den Berg JJ, Kiser PF, et al. The Promise of Intravaginal Rings for Prevention: User Perceptions of Biomechanical Properties and Implications for Prevention Product Development. PLoS One. 2015;10:e0145642. https:\/\/doi.org\/10.1371\/journal.pone.0145642.","journal-title":"PLoS One"},{"key":"5198_CR41","doi-asserted-by":"publisher","first-page":"124","DOI":"10.1007\/s10461-020-02949-4","volume":"25","author":"P Musara","year":"2021","unstructured":"Musara P, Milford C, Shapley-Quinn MK, Weinrib R, Mutero P, Odoom E, et al. Preferences and Acceptability of Vaginal Delivery Forms for HIV Prevention Among Women, Male Partners and Key Informants in South Africa and Zimbabwe: Qualitative Findings. AIDS Behav. 2021;25:124\u201338. https:\/\/doi.org\/10.1007\/s10461-020-02949-4.","journal-title":"AIDS Behav"},{"key":"5198_CR42","doi-asserted-by":"publisher","first-page":"16","DOI":"10.1016\/j.contraception.2021.10.001","volume":"106","author":"K Ridgeway","year":"2022","unstructured":"Ridgeway K, Montgomery ET, Smith K, Torjesen K, van der Straten A, Achilles SL, et al. Vaginal ring acceptability: A systematic review and meta-analysis of vaginal ring experiences from around the world. Contraception. 2022;106:16\u201333. https:\/\/doi.org\/10.1016\/j.contraception.2021.10.001.","journal-title":"Contraception"},{"key":"5198_CR43","doi-asserted-by":"publisher","first-page":"695","DOI":"10.2147\/IJWH.S34030","volume":"5","author":"AR Thurman","year":"2013","unstructured":"Thurman AR, Clark MR, Hurlburt JA, Doncel GF. Intravaginal rings as delivery systems for microbicides and multipurpose prevention technologies. Int J Womens Health. 2013;5:695\u2013708. https:\/\/doi.org\/10.2147\/IJWH.S34030.","journal-title":"Int J Womens Health"},{"key":"5198_CR44","doi-asserted-by":"publisher","first-page":"e0312957","DOI":"10.1371\/journal.pone.0312957","volume":"20","author":"BA Friedland","year":"2025","unstructured":"Friedland BA, Gundacker H, Achilles SL, Chen BA, Hoesley C, Richardson BA, et al. Acceptability of a dapivirine levonorgestrel vaginal ring in two Phase 1 trials (MTN-030\/IPM 041 and MTN-044\/IPM 053\/CCN019): Implications for multipurpose prevention technology development. PLoS ONE. 2025;20:e0312957. https:\/\/doi.org\/10.1371\/journal.pone.0312957.","journal-title":"PLoS ONE"},{"key":"5198_CR45","doi-asserted-by":"publisher","first-page":"144","DOI":"10.1111\/psrh.70009","volume":"57","author":"A Gottert","year":"2025","unstructured":"Gottert A, Friedland BA, Plagianos M, Zieman B, Sales JM, Atrio J, et al. Development and Validation of a Multidimensional Intravaginal Ring Acceptability Scale Among US Women and Their Male Partners. Perspect Sex Reprod Health. 2025;57:144\u201353. https:\/\/doi.org\/10.1111\/psrh.70009.","journal-title":"Perspect Sex Reprod Health"},{"key":"5198_CR46","doi-asserted-by":"publisher","first-page":"313","DOI":"10.1089\/AID.2021.0077","volume":"38","author":"I Hawley","year":"2022","unstructured":"Hawley I, Song M, Scheckter R, McClure T, Piper J, Chen BA, et al. Users\u2019 Preferred Characteristics of Vaginal Rings for HIV Prevention: A Qualitative Analysis of Two Phase I Trials. AIDS Res Hum Retroviruses. 2022;38:313\u201326. https:\/\/doi.org\/10.1089\/AID.2021.0077.","journal-title":"AIDS Res Hum Retroviruses"},{"key":"5198_CR47","unstructured":"Microbicide R&D to advance HIV prevention technology through responsive innovation and eXcellence (MATRIX). D2D Pillar 1 Report Round 2 Design Consultations (DC2). about-matrix.pdf. (2023). https:\/\/www.prepwatch.org\/wp-content\/uploads\/2022\/09\/about-matrix.pdf"},{"key":"5198_CR48","doi-asserted-by":"publisher","first-page":"S54","DOI":"10.1016\/j.antiviral.2013.09.029","volume":"100","author":"EE Tolley","year":"2013","unstructured":"Tolley EE, Morrow KM, Owen DH. Designing a multipurpose technology for acceptability and adherence. Antiviral Res. 2013;100:S54\u20139. https:\/\/doi.org\/10.1016\/j.antiviral.2013.09.029.","journal-title":"Antiviral Res"},{"key":"5198_CR49","doi-asserted-by":"publisher","first-page":"761","DOI":"10.1007\/s13346-017-0397-0","volume":"7","author":"KM Guthrie","year":"2017","unstructured":"Guthrie KM, Rosen RK, Vargas SE, Guillen M, Steger AL, Getz ML, et al. User input in iterative design for prevention product development: Leveraging interdisciplinary methods to optimize effectiveness. Drug Deliv Transl Res. 2017;7:761\u201370. https:\/\/doi.org\/10.1007\/s13346-017-0397-0.","journal-title":"Drug Deliv Transl Res"},{"key":"5198_CR50","doi-asserted-by":"publisher","first-page":"S40","DOI":"10.1016\/j.antiviral.2010.09.008","volume":"88","author":"KM Morrow","year":"2010","unstructured":"Morrow KM, Hendrix C. Clinical Evaluation of Microbicide Formulations. Antiviral Res. 2010;88:S40\u20136. https:\/\/doi.org\/10.1016\/j.antiviral.2010.09.008.","journal-title":"Antiviral Res"},{"key":"5198_CR51","doi-asserted-by":"publisher","first-page":"596","DOI":"10.1016\/j.contraception.2015.08.007","volume":"92","author":"RK Rosen","year":"2015","unstructured":"Rosen RK, van den Berg JJ, Vargas SE, Senocak N, Shaw JG, Buckheit RW, et al. Meaning-making matters in product design: users\u2019 sensory perceptions and experience evaluations of long-acting vaginal gels and intravaginal rings. Contraception. 2015;92:596\u2013601. https:\/\/doi.org\/10.1016\/j.contraception.2015.08.007.","journal-title":"Contraception"},{"key":"5198_CR52","doi-asserted-by":"publisher","first-page":"e0145642","DOI":"10.1371\/journal.pone.0145642","volume":"10","author":"K Morrow Guthrie","year":"2015","unstructured":"Morrow Guthrie K, Vargas S, Shaw JG, Rosen RK, van den Berg JJ, Kiser PF, et al. The Promise of Intravaginal Rings for Prevention: User Perceptions of Biomechanical Properties and Implications for Prevention Product Development. PLoS ONE. 2015;10:e0145642. https:\/\/doi.org\/10.1371\/journal.pone.0145642.","journal-title":"PLoS ONE"},{"key":"5198_CR53","doi-asserted-by":"publisher","first-page":"78","DOI":"10.1089\/aid.2013.0099","volume":"30","author":"KM Morrow","year":"2014","unstructured":"Morrow KM, Fava JL, Rosen RK, Vargas S, Shaw JG, Kojic EM, et al. Designing Preclinical Perceptibility Measures to Evaluate Topical Vaginal Gel Formulations: Relating User Sensory Perceptions and Experiences to Formulation Properties. AIDS Res Hum Retroviruses. 2014;30:78\u201391. https:\/\/doi.org\/10.1089\/aid.2013.0099.","journal-title":"AIDS Res Hum Retroviruses"},{"key":"5198_CR54","doi-asserted-by":"publisher","first-page":"19158","DOI":"10.7448\/IAS.17.3.19158","volume":"17","author":"KM MacQueen","year":"2014","unstructured":"MacQueen KM, Tolley EE, Owen DH, Amico KR, Morrow KM, Moench T, et al. An interdisciplinary framework for measuring and supporting adherence in HIV prevention trials of ARV-based vaginal rings. J Int AIDS Soc. 2014;17:19158. https:\/\/doi.org\/10.7448\/IAS.17.3.19158.","journal-title":"J Int AIDS Soc"},{"key":"5198_CR55","doi-asserted-by":"publisher","first-page":"e0197269","DOI":"10.1371\/journal.pone.0197269","volume":"13","author":"KM Guthrie","year":"2018","unstructured":"Guthrie KM, Rosen RK, Vargas SE, Getz ML, Dawson L, Guillen M, et al. User evaluations offer promise for pod-intravaginal ring as a drug delivery platform: A mixed methods study of acceptability and use experiences. PLoS ONE. 2018;13:e0197269. https:\/\/doi.org\/10.1371\/journal.pone.0197269.","journal-title":"PLoS ONE"},{"key":"5198_CR56","doi-asserted-by":"publisher","first-page":"1029","DOI":"10.1089\/jwh.2021.0121","volume":"31","author":"ST Roberts","year":"2022","unstructured":"Roberts ST, Hawley I, Luecke E, Mensch B, Wagner T, Hoesley C, et al. Acceptability and preference for 3-month versus 1-month vaginal rings for HIV-1 risk reduction among participants in a phase 1 trial. J Womens Health. 2022;31:1029\u201339. https:\/\/doi.org\/10.1089\/jwh.2021.0121.","journal-title":"J Womens Health"},{"key":"5198_CR57","doi-asserted-by":"publisher","first-page":"106935","DOI":"10.1016\/j.cct.2022.106935","volume":"122","author":"E McLellan-Lemal","year":"2022","unstructured":"McLellan-Lemal E, Deaton SR, Betts JE, Ondenge K, Mudhune V, O\u2019Connor SM, et al. Acceptability of an intravaginal ring for simultaneously preventing HIV infection and pregnancy: Qualitative findings of the Kisumu Combined Ring Study, 2019. Contemp Clin Trials. 2022;122:106935. https:\/\/doi.org\/10.1016\/j.cct.2022.106935.","journal-title":"Contemp Clin Trials"},{"key":"5198_CR58","doi-asserted-by":"publisher","first-page":"97","DOI":"10.1089\/apc.2022.0002","volume":"36","author":"MK Shapley-Quinn","year":"2022","unstructured":"Shapley-Quinn MK, Laborde N, Luecke E, Hoesley C, Salata RA, Johnson S, et al. Acceptability of the Dapivirine Vaginal Ring in Postmenopausal US Women. AIDS Patient Care STDs. 2022;36:97\u2013105. https:\/\/doi.org\/10.1089\/apc.2022.0002.","journal-title":"AIDS Patient Care STDs"},{"key":"5198_CR59","doi-asserted-by":"publisher","first-page":"607","DOI":"10.1007\/s10461-019-02457-0","volume":"24","author":"JA Bauermeister","year":"2020","unstructured":"Bauermeister JA, Golinkoff JM, Carballo-Di\u00e9guez A, Giguere R, L\u00f3pez D, Hoesley CJ, et al. A Mixed-Methods Study Examining Adherence to and Acceptability of Intravaginal Rings for HIV Prevention: Behavioral Results of MTN-027. AIDS Behav. 2020;24:607\u201316. https:\/\/doi.org\/10.1007\/s10461-019-02457-0.","journal-title":"AIDS Behav"},{"key":"5198_CR60","doi-asserted-by":"publisher","DOI":"10.1002\/jia2.25283","volume":"22","author":"ET Montgomery","year":"2019","unstructured":"Montgomery ET, Beksinska M, Mgodi N, Schwartz J, Weinrib R, Browne EN, et al. End-user preference for and choice of four vaginally delivered HIV prevention methods among young women in South Africa and Zimbabwe: the Quatro Clinical Crossover Study. J Int AIDS Soc. 2019;22:e25283. https:\/\/doi.org\/10.1002\/jia2.25283.","journal-title":"J Int AIDS Soc"},{"key":"5198_CR61","doi-asserted-by":"publisher","first-page":"465","DOI":"10.1080\/13697137.2023.2194526","volume":"26","author":"ML Hull","year":"2023","unstructured":"Hull ML, Stuckey B, Hartman K, Zack N, Thurman A, Friend DR. Safety and acceptability of intravaginal rings releasing estradiol and progesterone. Climacteric. 2023;26:465\u201371. https:\/\/doi.org\/10.1080\/13697137.2023.2194526.","journal-title":"Climacteric"},{"key":"5198_CR62","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0224898","volume":"14","author":"JB Griffin","year":"2019","unstructured":"Griffin JB, Ridgeway K, Montgomery E, Torjesen K, Clark R, Peterson J, et al. Vaginal ring acceptability and related preferences among women in low- and middle-income countries: A systematic review and narrative synthesis. PLoS One. 2019;14:e0224898. https:\/\/doi.org\/10.1371\/journal.pone.0224898.","journal-title":"PLoS One"},{"key":"5198_CR63","doi-asserted-by":"publisher","first-page":"1209","DOI":"10.1016\/j.jconrel.2024.10.059","volume":"376","author":"DK Dahl","year":"2024","unstructured":"Dahl DK, Srinivasan P, Janusziewicz R, King JL, Shrivastava R, Zhang J, et al. Next-generation 3D printed multipurpose prevention intravaginal ring for prevention of HIV, HSV-2, and unintended pregnancy. J Control Release. 2024;376:1209\u201324. https:\/\/doi.org\/10.1016\/j.jconrel.2024.10.059.","journal-title":"J Control Release"},{"key":"5198_CR64","doi-asserted-by":"publisher","first-page":"114430","DOI":"10.1016\/j.jconrel.2025.114430","volume":"389","author":"R Janusziewicz","year":"2026","unstructured":"Janusziewicz R, Shrivastava R, Knapp SF, Cottrell ML, Sykes C, Schauer A, et al. Sustained progesterone supplementation with state-of-the-art 3D printed intravaginal ring for the treatment of infertility. J Control Release. 2026;389:114430. https:\/\/doi.org\/10.1016\/j.jconrel.2025.114430.","journal-title":"J Control Release"},{"key":"5198_CR65","unstructured":"Snell W, Finney P. The multidimensional AIDS anxiety questionnaire. Handb Sex-Relat Meas. 1998;351\u20133."},{"key":"5198_CR66","doi-asserted-by":"publisher","unstructured":"Using the framework method. for the analysis of qualitative data in multi-disciplinary health research | BMC Medical Research Methodology | Full Text. (2025)\u00a0https:\/\/bmcmedresmethodol.biomedcentral.com\/articles\/https:\/\/doi.org\/10.1186\/1471-2288-13-117. Accessed 18 June 2025.","DOI":"10.1186\/1471-2288-13-117"},{"key":"5198_CR67","unstructured":"Ten top issues for. women\u2019s health. (2025)\u00a0https:\/\/www.who.int\/news-room\/commentaries\/detail\/ten-top-issues-for-women\u2019s-health. Accessed 18 June 2025."},{"key":"5198_CR68","doi-asserted-by":"publisher","first-page":"2423","DOI":"10.1111\/jan.12127","volume":"69","author":"DJ Ward","year":"2013","unstructured":"Ward DJ, Furber C, Tierney S, Swallow V. Using Framework Analysis in nursing research: a worked example. J Adv Nurs. 2013;69:2423\u201331. https:\/\/doi.org\/10.1111\/jan.12127.","journal-title":"J Adv Nurs"},{"key":"5198_CR69","doi-asserted-by":"publisher","first-page":"133","DOI":"10.1007\/s10461-017-1911-6","volume":"22","author":"R Weinrib","year":"2018","unstructured":"Weinrib R, Minnis A, Agot K, Ahmed K, Owino F, Manenzhe K, et al. End-Users\u2019 Product Preference Across Three Multipurpose Prevention Technology Delivery Forms: Baseline Results from Young Women in Kenya and South Africa. AIDS Behav. 2018;22:133\u201345. https:\/\/doi.org\/10.1007\/s10461-017-1911-6.","journal-title":"AIDS Behav"},{"key":"5198_CR70","doi-asserted-by":"publisher","first-page":"71","DOI":"10.1363\/psrh.12103","volume":"51","author":"SE Vargas","year":"2019","unstructured":"Vargas SE, Midoun MM, Guillen M, Getz ML, Underhill K, Kuo C, et al. A qualitative systematic review of women\u2019s experiences using contraceptive vaginal rings: implications for new technologies. Perspectives on Sexual and Reproductive Health. 2019;51:71\u201380. https:\/\/doi.org\/10.1363\/psrh.12103.","journal-title":"Perspectives on Sexual and Reproductive Health"},{"key":"5198_CR71","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0199096","volume":"13","author":"E Kestelyn","year":"2018","unstructured":"Kestelyn E, Nuil JIV, Umulisa MM, Umutoni G, Uwingabire A, Mwambarangwe L, et al. High acceptability of a contraceptive vaginal ring among women in Kigali, Rwanda. PLOS ONE. 2018;13:e0199096. https:\/\/doi.org\/10.1371\/journal.pone.0199096.","journal-title":"PLOS ONE"},{"key":"5198_CR72","doi-asserted-by":"publisher","DOI":"10.1101\/2021.06.15.21258958","author":"T Delvaux","year":"2021","unstructured":"Delvaux T, Jespers V, Benova L. Acceptability and satisfaction of contraceptive vaginal rings in clinical studies: a systematic review and narrative synthesis. medRxiv. 2021. https:\/\/doi.org\/10.1101\/2021.06.15.21258958.","journal-title":"medRxiv"},{"key":"5198_CR73","doi-asserted-by":"publisher","first-page":"1025","DOI":"10.1089\/jwh.2007.0529","volume":"17","author":"DJ Smith","year":"2002","unstructured":"Smith DJ, Wakasiaka S, Hoang TDM, Bwayo JJ, Del Rio C, Priddy FH. An evaluation of intravaginal rings as a potential HIV prevention device in urban Kenya: behaviors and attitudes that might influence uptake within a high-risk population. Journal of Women\u2019s Health. 2002;17:1025\u201334. https:\/\/doi.org\/10.1089\/jwh.2007.0529.","journal-title":"Journal of Women's Health"},{"key":"5198_CR74","doi-asserted-by":"publisher","first-page":"304","DOI":"10.1097\/QAI.0000000000002028","volume":"81","author":"A van der Straten","year":"1999","unstructured":"van der Straten A, Browne EN, Shapley-Quinn MK, Brown ER, Reddy K, Scheckter R, et al. First Impressions Matter: How Initial Worries Influence Adherence to the Dapivirine Vaginal Ring. J Acquir Immune Defic Syndr. 1999;81:304\u201310. https:\/\/doi.org\/10.1097\/QAI.0000000000002028.","journal-title":"J Acquir Immune Defic Syndr"},{"key":"5198_CR75","doi-asserted-by":"publisher","first-page":"2662","DOI":"10.1007\/s10461-018-2078-5","volume":"22","author":"AM Minnis","year":"2018","unstructured":"Minnis AM, Roberts ST, Agot K, Weinrib R, Ahmed K, Manenzhe K, et al. Young women\u2019s ratings of three placebo multipurpose prevention technologies for HIV and pregnancy prevention in a randomized, cross-over study in Kenya and South Africa. AIDS Behav. 2018;22:2662\u201373. https:\/\/doi.org\/10.1007\/s10461-018-2078-5.","journal-title":"AIDS Behav"},{"key":"5198_CR76","doi-asserted-by":"publisher","first-page":"3759","DOI":"10.1128\/AAC.00391-16","volume":"60","author":"JA Moss","year":"2016","unstructured":"Moss JA, Butkyavichene I, Churchman SA, Gunawardana M, Fanter R, Miller CS, et al. Combination Pod-Intravaginal Ring Delivers Antiretroviral Agents for HIV Prophylaxis: Pharmacokinetic Evaluation in an Ovine Model. Antimicrob Agents Chemother. 2016;60:3759\u201366. https:\/\/doi.org\/10.1128\/AAC.00391-16.","journal-title":"Antimicrob Agents Chemother"},{"key":"5198_CR77","doi-asserted-by":"publisher","first-page":"264","DOI":"10.1016\/j.contraception.2012.08.037","volume":"87","author":"V Brache","year":"2013","unstructured":"Brache V, Pay\u00e1n LJ, Faundes A. Current status of contraceptive vaginal rings. Contraception. 2013;87:264\u201372. https:\/\/doi.org\/10.1016\/j.contraception.2012.08.037.","journal-title":"Contraception"},{"key":"5198_CR78","doi-asserted-by":"publisher","first-page":"156","DOI":"10.3390\/pharmacy8030156","volume":"8","author":"JJ Virro","year":"2020","unstructured":"Virro JJ, Besinque K, Carney CE, Gross D, Bernick B, Mirkin S. Long-Lasting, Patient-Controlled, Procedure-Free Contraception: A Review of Annovera with a Pharmacist Perspective. Pharm Basel Switz. 2020;8:156. https:\/\/doi.org\/10.3390\/pharmacy8030156.","journal-title":"Pharm Basel Switz"},{"key":"5198_CR79","doi-asserted-by":"publisher","first-page":"953","DOI":"10.1080\/17512433.2019.1669448","volume":"12","author":"AL Nelson","year":"2019","unstructured":"Nelson AL. Comprehensive overview of the recently FDA-approved contraceptive vaginal ring releasing segesterone acetate and ethinylestradiol: A new year-long, patient controlled, reversible birth control method. Expert Rev Clin Pharmacol. 2019;12:953\u201363. https:\/\/doi.org\/10.1080\/17512433.2019.1669448.","journal-title":"Expert Rev Clin Pharmacol"},{"key":"5198_CR80","doi-asserted-by":"publisher","first-page":"775","DOI":"10.1007\/s13346-017-0385-4","volume":"7","author":"SK Patel","year":"2017","unstructured":"Patel SK, Rohan LC. On-demand microbicide products: design matters. Drug Deliv Transl Res. 2017;7:775\u201395. https:\/\/doi.org\/10.1007\/s13346-017-0385-4.","journal-title":"Drug Deliv Transl Res"}],"container-title":["AIDS and Behavior"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10461-026-05198-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s10461-026-05198-z","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10461-026-05198-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,9,3]],"date-time":"2026-09-03T16:18:05Z","timestamp":1788452285000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s10461-026-05198-z"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,9,3]]},"references-count":80,"alternative-id":["5198"],"URL":"https:\/\/doi.org\/10.1007\/s10461-026-05198-z","relation":{},"ISSN":["1090-7165","1573-3254"],"issn-type":[{"value":"1090-7165","type":"print"},{"value":"1573-3254","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,9,3]]},"assertion":[{"value":"1 June 2026","order":1,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"3 September 2026","order":2,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare the following financial interests\/personal relationships which may be considered as potential competing interests. SRB and RJ are inventors on a patent issued by the US PTO 507074848 describing geometrically complex intravaginal rings and their methods of fabrication and are co-founders of AnelleO, Inc., which has licensed this patent. SRB and RJ are also inventors on a patent application (U.S. Provisional Patent No. 63\/762,296) describing the fabrication of radially arrayed lattice architectures. There are no other competing interests to declare.","order":1,"name":"Ethics","label":"Conflict of interest","group":{"name":"EthicsHeading","label":"Declarations"}}]}}